Advanced Enzyme Technologies (NSE:ADVENZYMES) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ADVENZYMES Advanced Enzyme Technologies Ltd NSE:ADVENZYMES
89 GF Score
Price ₹324.35
GF Value ₹420.89
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Advanced Enzyme Technologies Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Advanced Enzyme Technologies Valuation Rank Related Terms

NSE:ADVENZYMES
89GF Score
Advanced Enzyme Technologies Ltd NSE:ADVENZYMES
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Advanced Enzyme Technologies (NSE:ADVENZYMES) Overvalued in 2026?

Based on GuruFocus' analysis, Advanced Enzyme Technologies stock appears to be undervalued. The current stock price of ₹324.35 is trading 22.9% below its estimated GF Value™ of ₹420.89. GuruFocus considers Advanced Enzyme Technologies to be Modestly Undervalued.

Key valuation signals for NSE:ADVENZYMES:

  • Valuation Rank:
  • GF Value™: ₹420.89 vs. price of ₹324.35 (22.9% below fair value)
  • GF Score™: 89/100 with 4 warning signs

No single metric tells the full story. See the NSE:ADVENZYMES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Advanced Enzyme Technologies Business Description

Other Exchanges 540025:India
Address Near LIC Service Road, Sun Magnetica, A Wing, 5th Floor, Louiswadi, Thane (West), Thane, MH, IND, 400604
Advanced Enzyme Technologies Ltd is an Indian company engaged in research activities to manufacture and sell enzymes. The company operates only in one business segment, viz., manufacturing and sales of enzymes. The company offers enzymes for human healthcare and nutrition, animal nutrition, food processing, and non-food processing. Some of the products offered by the company are serratiopeptidase, fungal lipase, papain, hemicellulose, and digegrain, among others. Geographically, the entity operates in India, Europe, the USA, Asia, and other countries, of which a majority of the revenue is derived from India.
89GF Score

Get the complete analysis for NSE:ADVENZYMES

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹324.35
Price
₹420.89
GF Value